![A European Model for an Organised Risk-stratified Early Detection Programme for Prostate Cancer - European Urology Oncology A European Model for an Organised Risk-stratified Early Detection Programme for Prostate Cancer - European Urology Oncology](https://euoncology.europeanurology.com/cms/asset/582a732d-abcf-418b-836b-aec1dc587797/gr1.jpg)
A European Model for an Organised Risk-stratified Early Detection Programme for Prostate Cancer - European Urology Oncology
![4kscore test, prostate cancer prevention trial-risk calculator y european research screening prostate-risk calculator en la predicción del cáncer de próstata de alto grado; estudio preliminar - Repositorio Institucional de Documentos 4kscore test, prostate cancer prevention trial-risk calculator y european research screening prostate-risk calculator en la predicción del cáncer de próstata de alto grado; estudio preliminar - Repositorio Institucional de Documentos](https://zaguan.unizar.es/record/78052/files/texto_completo.jpg?subformat=icon)
4kscore test, prostate cancer prevention trial-risk calculator y european research screening prostate-risk calculator en la predicción del cáncer de próstata de alto grado; estudio preliminar - Repositorio Institucional de Documentos
![A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc](https://www.urotoday.com/images/stories/Beyond_the_Abstract/bta_zhu_fig1c.jpg)
A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc
![Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI](https://www.bjuinternational.com/wp-content/uploads/2016/11/AOTWNov2.jpg)
Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI
![Adaptation and external validation of the European randomised study of screening for prostate cancer risk calculator for the Chinese population | Prostate Cancer and Prostatic Diseases Adaptation and external validation of the European randomised study of screening for prostate cancer risk calculator for the Chinese population | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fpcan.2016.57/MediaObjects/41391_2017_Article_BFpcan201657_Fig1_HTML.jpg)
Adaptation and external validation of the European randomised study of screening for prostate cancer risk calculator for the Chinese population | Prostate Cancer and Prostatic Diseases
![Cells | Free Full-Text | Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer Cells | Free Full-Text | Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer](https://www.mdpi.com/cells/cells-09-02116/article_deploy/html/images/cells-09-02116-g001.png)
Cells | Free Full-Text | Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer
![Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI](https://www.bjuinternational.com/wp-content/uploads/2016/11/AOTWNov-2-FI.jpg)
Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI
![Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth. Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.](https://d3i71xaburhd42.cloudfront.net/cfb41af6cecfb5f204e79875232cee8734801010/3-Table3-1.png)
Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.
Prediction of significant prostate cancer in biopsy-naïve men: Validation of a novel risk model combining MRI and clinical parameters and comparison to an ERSPC risk calculator and PI-RADS | PLOS ONE
![Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators - European Urology Focus Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/8e34ab0e-8920-4a8b-9c25-cdeb06947907/gr1_lrg.jpg)
Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators - European Urology Focus
![A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/34fd32696f2b1472725b338fc204d29585f2fe93/3-Figure1-1.png)
A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar
![Development and usability testing of the smartphone application Rotterdam Prostate Cancer Risk Calculator Development and usability testing of the smartphone application Rotterdam Prostate Cancer Risk Calculator](https://abstracts.mirrorsmed.org/sites/default/files/443-0.jpg)
Development and usability testing of the smartphone application Rotterdam Prostate Cancer Risk Calculator
![External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort - European Urology Focus External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/1c9dc49e-b7f0-494a-8696-a6fff2ae90ed/gr2_lrg.jpg)
External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort - European Urology Focus
![A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/34fd32696f2b1472725b338fc204d29585f2fe93/5-Figure2-1.png)
A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. | Semantic Scholar
![CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK](https://talkaboutprostatecancer.files.wordpress.com/2011/06/capra-s-rev.png?w=640)